The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.

MLA

Drelichman, Guillermo, et al. “The Road to Biosimilars in Rare Diseases - Ongoing Lessons from Gaucher Disease.” American Journal of Hematology, vol. 95, no. 3, Mar. 2020, pp. 233–37. EBSCOhost, https://doi.org/10.1002/ajh.25701.

APA

Drelichman, G., Castañeda-Hernández, G., Cem Ar, M., Dragosky, M., Garcia, R., Lee, H., Moiseev, S., Naderi, M., Rosenbaum, H., Žnidar, I., Zuluaga, A. F., Freisens, S., & Mistry, P. K. (2020). The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease. American Journal of Hematology, 95(3), 233–237. https://doi.org/10.1002/ajh.25701

Chicago

Drelichman, Guillermo, Gilberto Castañeda-Hernández, Muhlis Cem Ar, Marta Dragosky, Ricardo Garcia, Howard Lee, Sergey Moiseev, et al. 2020. “The Road to Biosimilars in Rare Diseases - Ongoing Lessons from Gaucher Disease.” American Journal of Hematology 95 (3): 233–37. doi:10.1002/ajh.25701.